Regulation of human β2-microglobulin transactivation in hematopoietic cells

Blood

Volumn 101, Issue 8, 2003, Pages 3058-3064

  Gobin, Sam J P ^a   Biesta, Paula ^a   Van Den Elsen, Peter J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 2; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 4; PROTEIN P50; SYNAPTOTAGMIN; TRANSCRIPTION FACTOR PU 1; AVIAN PROTEIN; BETA INTERFERON; BETA1A INTERFERON; DNA BINDING PROTEIN; GAMMA INTERFERON; HYBRID PROTEIN; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR 10, GALLUS GALLUS; INTERFERON REGULATORY FACTOR-10, GALLUS GALLUS; INTERFERON REGULATORY FACTOR-4; IRF1 PROTEIN, HUMAN; IRF2 PROTEIN, HUMAN; IRF3 PROTEIN, HUMAN; PHOSPHOPROTEIN; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; UPSTREAM STIMULATORY FACTOR; USF1 PROTEIN, HUMAN; USF2 PROTEIN, HUMAN;

ARTICLE; BINDING AFFINITY; BONE MARROW CELL; DNA RESPONSIVE ELEMENT; E BOX ELEMENT; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LYMPHOID CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REGULATORY MECHANISM; TRANSACTIVATION; TRANSCRIPTION REGULATION; BIOLOGICAL MODEL; BIOSYNTHESIS; CELL CULTURE; CELL LINE; DRUG EFFECT; GENETICS; INFECTION; INFLAMMATION; INJURY; LYMPHOCYTE; METABOLISM; REGULATORY SEQUENCE; SIGNAL TRANSDUCTION;

AVIAN PROTEINS; BETA 2-MICROGLOBULIN; CELL LINE, TRANSFORMED; DNA-BINDING PROTEINS; HUMANS; INFECTION; INFLAMMATION; INTERFERON REGULATORY FACTOR-1; INTERFERON REGULATORY FACTOR-2; INTERFERON REGULATORY FACTOR-3; INTERFERON REGULATORY FACTORS; INTERFERON TYPE II; INTERFERON-BETA; LYMPHOCYTES; MODELS, GENETIC; MYELOID CELLS; NF-KAPPA B; PHOSPHOPROTEINS; PROMOTER REGIONS (GENETICS); RECOMBINANT FUSION PROTEINS; REGULATORY SEQUENCES, NUCLEIC ACID; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; UPSTREAM STIMULATORY FACTORS; WOUNDS AND INJURIES;

EID: 0037606043     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-09-2924     Document Type: Article

References (50)

1. 2-microglobulin-binding site in class I major-histocompatibility-complex α-chains and proteins of related sequences. Biochem J. 1991;277:359-369.
2. Hudson AW, Ploegh HL. The cell biology of antigen presentation. Exp Cell Res. 2002;272:1-7.
3. Braud VM, Allan DS, McMichael AJ. Functions of nonclassical MHC and non-MHC-encoded class I molecules. Curr Opin Immunol. 1999;11:100-108.
4. O'Callaghan CA, Bell JI. Structure and function of the human MHC class Ib molecules HLA-E, HLA-F and HLA-G. Immunol Rev. 1998;163:129-138.
5. Moody DB, Besra GS. Glycolipid targets of CD1 mediated T-cell responses. Immunology. 2001;104:243-251.
6. Drakesmith H, Townsend A. The structure and function of HFE. Bioessays. 2000;22:595-598.
7. Waheed A, Grubb JH, Zhou XY, et al. Regulation of transferrin-mediated iron uptake by HFE, the protein defective in hereditary hemochromatosis. Proc Natl Acad Sci U S A. 2002;99:3117-3122.
8. 2-microglobulin knockout mice. Blood. 1998;91:3059-3065.
9. Parkkita S, Parkkila AK, Waheed A, et al. Cell surface expression of HFE protein in epithelial cells, macrophages, and monocytes. Haematologica. 2000;85:340-345.
10. Leach JL, Sedmak DD, Osborne JM, Rahill B, Lairmore MD, Anderson CL. Isolation from human placenta of the IgG transporter, FcRn, and localization to the syncytiotrophoblast: implications for maternal-fetal antibody transport. J Immunol. 1996;157:3317-3322.
11. 2-microglobulin in the term villous syncytiotrophoblast. Histochem Cell Biol. 2002;117:187-193.
12. 2-Microglobulin and bone cell metabolism. Nephrol Dial Transplant. 2001;16:1108-1111.
13. 2-microglobulin amyloidosis. Pathol Int. 2001;51:1-10.
14. 2-microglobulin, the light chain of the class I major histocompatibility complex, which is involved in human disease. Clin Sci (Lond). 2000;98:427-433.
15. 2-microglobulin. Nephron. 2002;90:158-168.
16. Gobin SJP, Peijnenburg A, van Eggermond M, van Zutphen M, van den Berg R, van den Elsen PJ. The RFX complex is crucial for the constitutive and CIITA-mediated transactivation of MHC class I and β2-microglobulin genes. Immunity. 1998;9:531-541.
17. Gobin SJP, van Zutphen M, Westerheide SD, Boss JM, van den Elsen PJ. The MHC-specific enhanceosome and its role in MHC class I and β2-microglobulin gene transactivation. J Immunol. 2001;167:5175-5184.
18. Luo X, Sawadogo M. Functional domains of the transcription factor USF2: atypical nuclear localization signals and context-dependent transcriptional activation domains. Mol Cell Biol. 1996;16:1367-1375.
19. Lin R, Mamane Y, Hiscott J. Structural and functional analysis of interferon regulatory factor 3: localization of the transactivation and autoinhibitory domains. Mol Cell Biol. 1999;19:2465-2474.
20. Lin R, Mamane Y, Hiscott J. Multiple regulatory domains control IRF-7 activity in response to virus infection. J Biol Chem. 2000;275:3432034327.
21. 2-microglobulin genes. Proc Natl Acad Sci U S A. 1987;84:2653-2657.
22. Dey A, Thornton AM, Lonergan M, Weissman SM, Chamberlain JW, Ozato K. Occupancy of upstream regulatory sites in vivo coincides with major histocompatibility complex class I gene expression in mouse tissues. Mol Cell Biol. 1992;12:3590-3599.
23. Tamura T, Ozato K. ICSBP/IRF-8: its regulatory roles in the development of myeloid cells. J Interferon Cytokine Res. 2002;22:145-152.
24. Van den Elsen PJ, Gobin SJ, van Eggermond MC, Peijnenburg A. Regulation of MHC class I and II gene transcription: differences and similarities. Immunogenetics. 1998;48:208-221.
25. Gobin SJP, Keijsers V, van Zutphen M, van den Elsen PJ. The role of enhancer A in the locus-specific transactivation of classical and nonclassical HLA class I genes by nuclear factor KB. J Immunol. 1998;161:2276-2283.
26. Gobin SJP, van Zutphen M, Woltman AM, van den Elsen PJ. Transactivation of classical and nonclassical HLA class I genes through the IFN-stimulated response element. J Immunol. 1999;163:1428-1434.
27. Fruh K, Yang Y. Antigen presentation by MHC class I and its regulation by interferon γ. Curr Opin Immunol. 1999;11:76-81.
28. Hallermalm K, Seki K, Wei C, et al. Tumor necrosis factor-α induces coordinated changes in major histocompatibility class I presentation pathway, resulting in increased stability of class I complexes at the cell surface. Blood. 2001;98:1108-1115.
29. Pine R. Convergence of TNFα and IFNγ/signalling pathways through synergistic induction of IRF-1/ISGF-2 is mediated by a composite GAS/κB promoter element. Nucleic Acids Res. 1997;25:4346-4354.
30. Boehm U, Klamp T, Groot M, Howard JC. Cellular responses to interferon-γ. Annu Rev Immunol. 1997;15:749-795.
31. Agresti C, Bernardo A, Del Russo N, et al. Synergistic stimulation of MHC class I and IRF-1 gene expression by IFN-γ and TNF-α in oligodendrocytes. Eur J Neurosci. 1998;10:2975-2983.
32. Nguyen VT, Benveniste EN. Critical role of tumor necrosis factor-α and NF-αB in interferon-γ-induced CD40 expression in microglia/macrophages. J Biol Chem. 2002;277:13796-13803.
33. Caamaño J, Hunter CA, NF-κB family of transcription factors: central regulators of innate and adaptive immune functions. Clin Microbiol Rev. 2002;15:414-429.
34. Mamane Y, Sharma S, Grandvaux N, Hernandez E, Hiscott J. IRF-4 activities in HTLV-I-induced T cell leukemogenesis. J Interferon Cytokine Res. 2002;22:135-143.
35. Pernis AB. The role of IRF-4 in B and T cell activation and differentiation. J Interferon Cytokine Res. 2002;22:111-120.
36. Meraro D, Gleit-Kielmanowicz M, Hauser H, Levi BZ. IFN-stimulated gene 15 is synergistically activated through interactions between the myelocyte/lymphocyte-specific transcription factors, PU.1, IFN regulatory factor-8/IFN consensus sequence binding protein, and IFN regulatory factor-4: characterization of a new subtype of IFN-stimulated response element. J Immunol. 2002;168:6224-6231.
37. Taniguchi T, Ogasawara K, Takaoka A, Tanaka N. IRF family of transcription factors as regulators of host defense. Annu Rev Immunol. 2001;19:623-655.
38. Hobart M, Ramassar V, Goes N, Urmson J, Halloran PF. IFN regulatory factor-1 plays a central role in the regulation of the expression of class I and II MHC genes in vivo. J Immunol. 1997;158:4260-4269.
39. Lin R, Genin P, Mamane Y, Hiscott J. Selective DNA binding and association with the CREB binding protein coactivator contribute to differential activation of α/β interferon genes by interferon regulatory factors 3 and 7. Mol Cell Biol. 2000;20:6342-6353.
40. Grandvaux N, Servant MJ, ten Oever B, et al. Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes. J Virol. 2002;76:5532-5539.
41. Morin P, Braganca J, Bandu MT, et al. Preferential binding sites for interferon regulatory factors 3 and 7 involved in interferon-A gene transcription. J Mol Biol. 2002;316:1009-1022.
42. Levi BZ, Hashmueli S, Gleit-Kielmanowicz M, Azriel A, Meraro D. ICSBP/IRF-8 transactivation: a tale of protein-protein interaction. J Interferon Cytokine Res. 2002;22:153-160.
43. Marecki S, Fenton MJ. PU.1/Interferon regulatory factor interactions: mechanisms of transcriptional regulation. Cell Biochem Biophys. 2000;33:127-148.
44. Marecki S, Fenton MJ. The role of IRF-4 in transcriptional regulation. J Interferon Cytokine Res. 2002;22:121-133.
45. Verger A, Duterque-Coquillaud M. When Ets transcription factors meet their partners. Bioessays. 2002;24:362-370.
46. Graves BJ, Petersen JM. Specificity within the ets family of transcription factors. Adv Cancer Res. 1998;75:1-55.
47. Nagulapalli S, Atchison ML. Transcription factor Pip can enhance DNA binding by E47, leading to transcriptional synergy involving multiple protein domains. Mol Cell Biol. 1998;18:4639-4650.
48. Meraro D, Hashmueli S, Koren B, et al. Protein-protein and DNA-protein interactions affect the activity of lymphoid-specific IFN regulatory factors. J Immunol. 1999;163:6468-6478.
49. Pine R. IRF1 and tuberculosis. J Interferon Cytokine Res. 2002;22:15-25.
50. Servant MJ, Ten Oever B, Lin R. Overlapping and distinct mechanisms regulating IRF-3 and IRF-7 function. J Interferon Cytokine Res. 2002;22:49-58.